Prospects in the Immunological Treatments of Rheumatoid Arthritis

References

• Adelman N. E., Watling D. L., Mc Devitt H. O. Treatment of (NZB/NZW, FI disease with anti-Ia monoclonal antibodies. J. Exp. Med. 1983; 158: 1350
   PubMed Web of Science ®Google Scholar
• Amor B., Dougados M., Mery C., De Gery A., Choay J., Dardenne M, Bach J.F. Thymuline (FTS) in rheumatoid arthritis. Arthritis and Rheumatism 1984; 27: 117
   PubMedGoogle Scholar
• Bailin P. L., Tindal J. P., Roenigk H. H., Hogan M. D. Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. Journal of The American Medical Association 1975; 232: 359
   PubMed Web of Science ®Google Scholar
• Bertouch J. V., Roberts-Thomson P. J., Smith M. D., Woodruff T. B., Brooks P. M., Bradley J. Metkylprednisolone infusion therapy in rheumatoid arthritis patients: the effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis and Rheumatism 1986; 29: 32
   PubMedGoogle Scholar
• Bitter T. Combined disease modifying chemotherapy for intractable rheumatoid arthritis. Clinics in rheumatic diseases, E.C. Huskisson. W.B. Saunders, London 1984; 417
   Google Scholar
• Christophidis N. Methotrexate. Clinics in rheumatic diseases, E.C. Huskisson. W.B. Saunders, London 1984; 401
   Google Scholar
• Clot J., Moynier M., Cosso B., Brochier J. Human placenta eluates contain anticlass II HLA alloantibodies. Immune intervention 2 Anti-la antibodies in the treatment of autoimmun disease, J. Brochier, J. Clot, J. Sany. Academic Press, London 1986; 73
   Google Scholar
• Clot J., Sany J. Anti-Ia like antibodies: preliminary use in rheumatoid arthritis. Immunol. Today 1984; 5: 126
   PubMedGoogle Scholar
• Combe B., Cosso B., Clot J., Bonneau M., Sany J. Human placenta eluted gammaglobulins in immunomodulating treatment of rheumatoid arthritis. American Journal of Medicine 1985; 78: 920
   PubMed Web of Science ®Google Scholar
• Combe B., Pope R. M., Fischbach M., Darnel B., Baron S., Talal N. Interleukin 2 in rheumatoid arthritis: production of and response to interleukin 2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin. Exp. Immunol 1985; 59: 520
   PubMed Web of Science ®Google Scholar
• Dougados M., Amor B. Traitement it la polyarthrite rhumatoide par la ciclosporine. Revue du Rhumatisme 1986; 53: 283
   PubMedGoogle Scholar
• Goldstein R., Blanchette U. S., Huebesch L. B., McKendry J. R. Treatment of gold induced thrombocytopenia by high dose intravenous gammaglobulins. Arthritis and Rheumatism 1986; 29: 426
   PubMedGoogle Scholar
• Hanly J. G., Hassan J., Moriarty M., Barry C., Molony J., Casey E., Whelan A., Feighery C., Bresnihan B. Lymphoid irradiation in intractable rheumatoid arthritis: a double blind, randomized study comparing 750 mi treatment with 2000 rad treatment. Arthritis and Rheumatism 1986; 29: 16
   PubMedGoogle Scholar
• Harris E.W. Rheumatoid arthritis: the clinical spectrum. Textbook of Rheumatology, W.N. Kelley, E.W. Harris, S. Ruddy, C.B. Sledge. W.B. Saunders, Philadelphia 1981; 377
   Google Scholar
• Klinman D. N., Lefkowitz M., Honda M., Barret R., Steinberg A. D. Suppression of autoantibody production with anticlass II antibodies. Immune intervention 2 Anti-la antibodies in the treatment of autoimmune disease, J. Brochier, J. Clot, J. Sany. Academic Press, London 1986; 87
   Google Scholar
• Klinman D. N., Steinberg A. D. Idiotypy and autoimmunity. Arthritis and Rheumatism 1986; 29: 697
   PubMed Web of Science ®Google Scholar
• Kotzin B. L., Kansas G. S., Engleman E. G., Hoppe T., Kaplan H. S., Strober S. Changes in T cell subsets in patients with rheumatoid arthritis treated with total lymphoid irradiation. Clinical Immunology and Immunopathology 1983; 27: 250
   PubMedGoogle Scholar
• Kotzin B. L., Strober S., Engleman E. G., Calin A., Hoppe R. T., Kansas G. S., Terrel C. P., Kaplan H. S. Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N. Engl. J. Med. 1981; 305: 969
   PubMed Web of Science ®Google Scholar
• Kremer J. M., Michalek A. V., Lininger L., Huyck C., Bigauotte J., Jimchalk M. A., Rynes R. I., Zieminski Bartholomew J. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985; 1: 184
   PubMed Web of Science ®Google Scholar
• Lee T. H., Hoover R. L., Williams J. D., Sperling R. I., Ravalese J., Spur B. W., Robinson D. R., Corey E. J., Lewis R. A., Austen F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985; 312: 1217
   PubMed Web of Science ®Google Scholar
• Lemmel E. M., Franke M., Gaus W., Hard P. W., Hotschneider P. H., Machalke M., Miehlke K., Wilms P., Obert H. J. Recombinant human gamma interferon (IF) in the treatment of rheumatoid arthritis (RA): a multicenter phase II trial. Arthritis and Rheumatism 1986; 29: S79, (Suppl.)
   Google Scholar
• Lewis P., Hazelman B., Bulgen D. Clinical and immunological study of high dose azathioprine combined with gold therapy. Rheumatoid arthritis, cellular pathology and pharmacology, J.L. Gordon, B.L. Hazelman, North Holland, Amsterdam 1977; 280
   Google Scholar
• Mc Carty D. J., Guilliermo F., Carrera F. Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. Journal of The American Medical Association 1982; 248: 1718
   Google Scholar
• Malaise M. G., Hauwaert C., Franchimont P., Danneskiol D., Samsoe D. B., Bachandersen R., Gross D., Gerber H., Gerschpacher H., Stocker H., Bolla K. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double blind placebo controlled randomized study. Lancet 1985; 1: 832
   PubMedGoogle Scholar
• Miller L. C., Dinarello C. A. Methotrexate inhibits interleukin 1 activity. Arthritis and Rheumatism 1986; 29: S86, (Suppl.)
   Google Scholar
• Miossec P., Kashidwado T., Ziff M. Inhibitor of interleukine 2 in rheumatoid synovial fluid. Arthritis and Rheumatism 1986; 29: S28
   Google Scholar
• Nusslein H. G., Herbst M., Manger B. J., Gramatzki M., Burmester G., Fritz H., Sauer R., Kalden J. R. Total lymphoid irradiation in patients with refractory rheumatoid arthritis. Arthritis and Rheumatism 1985; 28: 1205
   PubMedGoogle Scholar
• Sany J., Clot J., Bonneau M., Andary M. Immunomodulating effect of human placenta eluted gammaglobulins in rheumatoid arthritis. Arthritis and Rheumatism 1982; 25: 17
   PubMed Web of Science ®Google Scholar
• Skoldstam L., Lindstrom F. D., Lindblom B. Impaired Con A suppressor cell activity in patients with rheumatoid arthritis shows normalization during fasting. Scand. J. Rheumatology 1983; 12: 369
   PubMedGoogle Scholar
• Steinman L., Zamuil S. S., O'Hearn M., Schwartz G., Sriram S., Mitchell D., Waldor M. K. Experiences with anti-Ia therapy in the mouse and in the monkey and, the applications to human protocoles. Immune intervention 2. Anti-Ia antibodies in the treatment of autoimmune disease, J. Brochier, J. Clot, J. Sany. Academic Press, London 1986; 109
   Google Scholar
• Tanay A., Schiffman G., Strober S. Effect of total lymphoid irradiation on levels of serum auto antibodies in systemic lupus erythematosus and in rheumatoid arthritis. Arthritis and Rheumatism 1986; 29: 26
   PubMedGoogle Scholar
• Trentham D. E., Belli J. A., Anderson R. J., Buckley J. A., Goetzl E. J., David J. R., Austen K. F. Clinical and immunological effect of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N. Engl. J. Med. 1981; 305: 976
   PubMedGoogle Scholar
• Truckenbrodt H., Hafner R. Methotrexate study in juvenile rheumatoid arthritis. A retrospective study. Arthritis and Rheumatism 1986; 29: 801
   PubMed Web of Science ®Google Scholar
• Tsubakio T., Kurata Y., Katagiri S., Kanakura Y., Tamaki T., Kuyama J., Kanayama Y., Yonezawa T., Tarui S. Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gammaglobulin therapy in patients with idiopathic thrombocytopenic purpura. Clin. Exp. Immunol. 1983; 53: 697
   PubMed Web of Science ®Google Scholar
• Van Rijthoven A. W., Dijkmans B. A.C., The H. S.G., Jacobs P. J.C., Cats A. Ciclosporin treatment in rheumatoid arthritis; a multicentre placebo controlled double blind study. Arthritis and Rheumatism 1986; 29: S19, (Suppl.)
   Google Scholar
• Veys E. M., Mielants H., Verbrugger G. Thymopoietin pentapeptide (Thymopenin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short and long term clinical studies. J. Rheumatol. 1984; 11: 462
   PubMed Web of Science ®Google Scholar
• Voisin G. A., Chaouat G. Demonstration, nature and properties of maternal antibodies fixed on placenta and directed against paternal antigens. J. Reprod Fertil. 1974; 21: 89
   Google Scholar
• Williams J. H., Wilkens R. F., Samuelson G. O., Alarcon G. S., Guttadauria M., Yarboro C., Polisson R. P., Weiner S. R., Luggen M. E., Billingsley L. M., Dahl S. L., Egger M. L., Reading J. C., Ward J. R. Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis and Rheumatism 1985; 28: 721
   PubMed Web of Science ®Google Scholar
• Wolfe F., Cathey M. A., Hawley D. J., Schindler J. Recombinant gamma interferon in rheumatoid arthritis. Arthritis and Rheumatism 1986; 29: S18, (Suppl.)
   Google Scholar
• Wolley P. H., Luthra H. S., Lafuse W. P., Huse A., Stuart J. M., David C. S. Type II collagen induced arthritis in mice. III—Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. The Journal of Immunology 1985; 134: 2366
   PubMedGoogle Scholar
• Ziff M. Current comment: diet in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 1983; 26: 457
   PubMed Web of Science ®Google Scholar